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In the early days of transplantation, organs to be
used for transplantation were stored by continuous cold
perfusion  (CCP) in the period between removal from
the donor patient and subsequent grafting. However,
the equipments for CCP were unreliable, costly and
difficult to transport between hospitals. Therefore,
during the past 20 years, clinical organ transplantation
across the UK and Europe has developed on the basis
of  the ‘cold flush’ method where organ  have been
preserved on ice after vascular flush with  specially-
designed cold flush solutions. The main cold flush
solution has been University of Wisconsin solution, but
others have also been developed. However, over the
years, the success of organ transplantation has meant
that there are growing numbers of patients who could
benefit from transplantation, but a shortage of suitable
donor organs. This has led to a great  pressure to
expand the criteria for accepting less-than-optimal
organs which have experienced considerable warm
hypoxia before cold preservation (the so-called non-
heart beating donor  – NHBD organs). Experimental
evidence has shown that continuous cold perfusion with
oxygenated solutions can repair some of the damage
which took place in the NHBD organs  and so the
preservation period can be used to ‘rescue’ and
improve these organs to achieve good results in
transplantation. This has led to the development in the
past 2 years of a new generation of hypothermic
perfusion machines for kidneys and livers, which are
being studied in trials in Europe. These developments
will be discussed.
